In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: An update from the Pediatric AIDS Clinical Trials Group 219 and 219C cohorts

被引:20
作者
Brogly, S [1 ]
Williams, P
Seage, GR
Van Dyke, R
机构
[1] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Tulane Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70118 USA
关键词
D O I
10.1097/01.qai.0000194735.66322.d9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:535 / 536
页数:2
相关论文
共 5 条
[1]  
[Anonymous], PUBL HLTH SERV TASK
[2]   Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine [J].
Hanson, IC ;
Antonelli, TA ;
Sperling, RS ;
Oleske, JM ;
Cooper, E ;
Culnane, M ;
Fowler, MG ;
Kalish, LA ;
Lee, SS ;
McSherry, G ;
Mofenson, L ;
Shapiro, DE .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 20 (05) :463-467
[3]   Current views in HTLV-I-associated adult T-cell leukemia/lymphoma [J].
Nicot, C .
AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (03) :232-239
[4]   Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs [J].
Poirier, MC ;
Olivero, OA ;
Walker, DM ;
Walker, VE .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 199 (02) :151-161
[5]  
Ries L., 2004, SEER CANC STAT REV 1